enbucrilate has been researched along with paclitaxel in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, S; Mitra, A | 1 |
| Chen, CM; Huang, CY; Lee, YD | 1 |
| He, M; Tang, C; Yin, C; Yin, L; Zhao, Z | 1 |
| Chen, RD; Li, GF; Liu, SJ; Ren, F | 1 |
| Chen, R; Jiang, Y; Li, G; Ren, F; Sun, Y; Wang, Y | 1 |
| Jiang, X; Wang, L; Wu, Y; Zhang, K; Zhang, X; Zhou, L; Zhu, C | 1 |
6 other study(ies) available for enbucrilate and paclitaxel
| Article | Year |
|---|---|
Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.
Topics: Antineoplastic Agents, Phytogenic; Drug Carriers; Enbucrilate; Kinetics; Nanotechnology; Paclitaxel; Particle Size; Solubility; Surface Properties; Surface-Active Agents | 2003 |
Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion.
Topics: Emulsions; Enbucrilate; Nanoparticles; Paclitaxel; Poloxamer; Solubility; X-Ray Diffraction | 2007 |
Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Cell Line, Tumor; Cell Survival; Cerium; Drug Carriers; Enbucrilate; Hemolysis; Humans; Hyaluronic Acid; Magnetic Resonance Spectroscopy; Male; Materials Testing; Mice; Mice, Inbred Strains; Microscopy, Electron, Transmission; Nanoparticles; Nitrates; Paclitaxel; Particle Size; Rabbits; Sarcoma 180; Spectroscopy, Fourier Transform Infrared; Static Electricity; X-Ray Diffraction | 2009 |
[Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles].
Topics: Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Enbucrilate; Nanoparticles; Paclitaxel; Polymerization | 2010 |
Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enbucrilate; Female; Humans; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Reverse Transcriptase Polymerase Chain Reaction; Solubility; Surface Properties | 2011 |
N-Butyl-2-cyanoacrylate-based injectable and in situ-forming implants for efficient intratumoral chemotherapy.
Topics: Animals; Enbucrilate; Humans; Mice; Paclitaxel; Phase Transition | 2017 |